Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics ... spatial biology. Our GEM-X technology has been delivering great advances to single cell analysis. Visium ...

As you might know, 10x Genomics, Inc. (NASDAQ:TXG) just kicked off its latest quarterly results with some very strong numbers. The results overall were pretty good, with revenues of US$155m ...

10x Genomics (NASDAQ:TXG) develops instruments, consumables, and software that enable researchers to analyze biological systems at single-cell resolution and spatial context. A company’s long ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it ...